Cargando…
Wait times for breast cancer care
Measurement of care time intervals is complex, being influenced by many factors. The definition of the care interval monitored can also bias the detection of changes in waits. The implications of using different care interval definitions to report wait times and identify delays in care provision wer...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360218/ https://www.ncbi.nlm.nih.gov/pubmed/17179986 http://dx.doi.org/10.1038/sj.bjc.6603523 |
_version_ | 1782152993847640064 |
---|---|
author | Saint-Jacques, N Younis, T Dewar, R Rayson, D |
author_facet | Saint-Jacques, N Younis, T Dewar, R Rayson, D |
author_sort | Saint-Jacques, N |
collection | PubMed |
description | Measurement of care time intervals is complex, being influenced by many factors. The definition of the care interval monitored can also bias the detection of changes in waits. The implications of using different care interval definitions to report wait times and identify delays in care provision were examined using a retrospective chart review of 637 women with surgically treated breast cancer who were referred to a cancer centre between September 1999 and 2000 or September 2003 and 2004. Overall waits between detection and adjuvant treatment increased by 12 days over the two periods, but their exact location and cause(s) could not be determined at such a low-resolution interval. At higher resolutions of care intervals, reporting the comprehensive sequence of care events, the prolongation was mainly associated with delayed access to surgery (4 days) and delivery of adjuvant chemotherapy (4 days). The latter went unnoticed when waits were reported at intermediate (referral to adjuvant treatment) and low (detection to adjuvant treatment) resolutions. Disease stage and type of first adjuvant treatment consistently and significantly influenced the length of waits. Comprehensive monitoring of the entire care path is essential to effectively prioritize interventions, assess their outcomes and optimise access to cancer care. |
format | Text |
id | pubmed-2360218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23602182009-09-10 Wait times for breast cancer care Saint-Jacques, N Younis, T Dewar, R Rayson, D Br J Cancer Epidemiology Measurement of care time intervals is complex, being influenced by many factors. The definition of the care interval monitored can also bias the detection of changes in waits. The implications of using different care interval definitions to report wait times and identify delays in care provision were examined using a retrospective chart review of 637 women with surgically treated breast cancer who were referred to a cancer centre between September 1999 and 2000 or September 2003 and 2004. Overall waits between detection and adjuvant treatment increased by 12 days over the two periods, but their exact location and cause(s) could not be determined at such a low-resolution interval. At higher resolutions of care intervals, reporting the comprehensive sequence of care events, the prolongation was mainly associated with delayed access to surgery (4 days) and delivery of adjuvant chemotherapy (4 days). The latter went unnoticed when waits were reported at intermediate (referral to adjuvant treatment) and low (detection to adjuvant treatment) resolutions. Disease stage and type of first adjuvant treatment consistently and significantly influenced the length of waits. Comprehensive monitoring of the entire care path is essential to effectively prioritize interventions, assess their outcomes and optimise access to cancer care. Nature Publishing Group 2007-01-15 2006-12-19 /pmc/articles/PMC2360218/ /pubmed/17179986 http://dx.doi.org/10.1038/sj.bjc.6603523 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Epidemiology Saint-Jacques, N Younis, T Dewar, R Rayson, D Wait times for breast cancer care |
title | Wait times for breast cancer care |
title_full | Wait times for breast cancer care |
title_fullStr | Wait times for breast cancer care |
title_full_unstemmed | Wait times for breast cancer care |
title_short | Wait times for breast cancer care |
title_sort | wait times for breast cancer care |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360218/ https://www.ncbi.nlm.nih.gov/pubmed/17179986 http://dx.doi.org/10.1038/sj.bjc.6603523 |
work_keys_str_mv | AT saintjacquesn waittimesforbreastcancercare AT younist waittimesforbreastcancercare AT dewarr waittimesforbreastcancercare AT raysond waittimesforbreastcancercare |